Your browser doesn't support javascript.
loading
Can the systemic immune-inflammation index be used as a novel diagnostic tool in the diagnosis of subacute thyroiditis?
Keskin, Çaglar; Dilekçi, Esra Na; Üç, Ziynet A; Cengiz, Deniz; Duran, Cevdet.
Afiliación
  • Keskin Ç; Department of Endocrinology & Metabolism, Bolu Abant Izzet Baysal University School of Medicine, Bolu, 14030, Turkey.
  • Dilekçi EN; Department of Endocrinology & Metabolism, Bolu Abant Izzet Baysal University School of Medicine, Bolu, 14030, Turkey.
  • Üç ZA; The Department of Internal Medicine, The Division of Endocrinology & Metabolism, Usak University School of Medicine, Usak, 64200, Turkey.
  • Cengiz D; Department of Internal Medicine, Bolu Abant Izzet Baysal University School of Medicine, Bolu, 14030, Turkey.
  • Duran C; The Department of Internal Medicine, The Division of Endocrinology & Metabolism, Usak University School of Medicine, Usak, 64200, Turkey.
Biomark Med ; 16(10): 791-797, 2022 07.
Article en En | MEDLINE | ID: mdl-35748139
ABSTRACT

Aim:

To evaluate systemic inflammatory parameters derived from hematological parameters in the diagnosis and prognosis of subacute thyroiditis (SAT).

Methods:

Demographic and laboratory data of 170 patients with SAT and 91 healthy control subjects were analysed retrospectively. The authors compared inflammatory parameters and thyroid function tests between SAT and control groups.

Results:

The erythrocyte sedimentation rate, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammatory index (SII) were significantly higher in patients with SAT (p < 0.001). There was a significant positive correlation between the SII and erythrocyte sedimentation rate (r 0.448; p < 0.001), CRP (r 0.449; p < 0.01), neutrophil-to-lymphocyte ratio (r 0.861; p < 0.001) and platelet-to-lymphocyte ratio (r 0.782, p < 0.001). The thyroid stimulating hormone levels were higher in patients with recurrence when compared with those without recurrence (p = 0.007).

Conclusions:

As a practical biomarker, SII was significantly higher in patients with SAT compared with the control group. SII may be a new diagnostic tool for SAT.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiroiditis Subaguda Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiroiditis Subaguda Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Turquía